You are here: Industry Insights > COVID-19 Vaccine

News List

FDA grants Fast Track Designation to Novavax COVID-19 vaccine candidate europeanpharmaceuticalreview
November 13, 2020
The FDA has given Fast Track Designation to NVX-CoV2373, Novavax’s COVID-19 vaccine candidate, created using recombinant nanoparticle technology.
IMCR and SII collaborate to develop Novavax’s Covid-19 vaccine in India pharmaceutical-technology
November 13, 2020
Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) have collaborated for clinical development of the Covid-19 vaccine, COVOVAX, by US-based firm Novavax and upscaled by SII.
Govt allots R&D grant of Rs 900 crores for COVID-19 vaccine development expresspharma
November 13, 2020
Nirmala Sitharaman, Finance Minister of India, announcing the details of the third stimulus package, informed that Rs 900 crores would be provided for Covid Suraksha Mission.
Russian says its ‘Sputnik V’ COVID-19 vaccine is 92% effective pharmatimes
November 12, 2020
A COVID-19 vaccine developed by the Gamaleya Center in Russia is 92% effective, the Russian Direct Investment Fund (RDIF) said yesterday.
SinoVac gets authorisation to restart Covid-19 vaccine trial in Brazil pharmaceutical-technology
November 12, 2020
Chinese biopharmaceutical firm Sinovac is set to resume the Phase III trial of the Inactivated Covid-19 vaccine, CoronaVaC, after the Brazil National Health Surveillance Agency (Anvisa) authorised its resumption.
Medicago’s COVID-19 vaccine elicits immune response in early-stage study expresspharma
November 12, 2020
Medicago did not disclose full safety data, but said side effects were mainly mild to moderate.
Inadequate cold chain infra may limit India’s access to Pfizer’s COVID-19 vaccine expresspharma
November 12, 2020
Pfizer’s vaccine needs to stored and transported at -70 degree Celsius to maintain its efficacy.
Novavax COVID-19 vaccine granted Fast Track Designation by U.S. FDA worldpharmanews
November 11, 2020
Novavax, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for NVX-CoV2373, the Company’s COVID-19 vaccine candidate.
ImmunityBio reports positive data from Covid-19 vaccine trial pharmaceutical-technology
November 11, 2020
ImmunityBio has reported positive study results for its novel vaccine candidate, hAd5-COVID-19, which showed memory T-cell recall from patients previously infected with SARS-CoV-2, a virus that causes Covid-19.
COVID-19 vaccine over 90 per cent effective: Pfizer expresspharma
November 10, 2020
Pfizer and BioNTech said they have so far found no serious safety concerns and expect to seek US authorisation this month for emergency use of the vaccine.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page